What is Biostem Technologies Inc?
engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 76.52M, and a P/E ratio of 5.2x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.